Bradley Barth
Pediatric Gastroenterology · Dallas, TXNPI 1982666848
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,855 of the $6,272 with a category attached, or 61.5%. Olympus Medical Systems Corporation accounts for 61.5% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $2,499, 5.4 times the $467 reported in 2019.
Across 84 payments — averaging $74.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Medical Systems Corporation$4K
- Takeda Pharmaceuticals U.S.A., Inc.$413
- Regeneron Healthcare Solutions, Inc.$284
- QOL Medical, LLC$282
- Johnson & Johnson$230
- Mirum Pharmaceuticals, Inc.$230
- plus $978 from 14 others
Across 1 payment — averaging $400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pharmacyclics LLC, An Abbvie Company$400
What the payments were for
- Consulting fees$3,85561%
- Food & beverage$2,32137%
- Education$962%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Medical Systems Corporation | 2 | $3,855 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $413 |
| Regeneron Healthcare Solutions, Inc. | 8 | $284 |
| QOL Medical, LLC | 9 | $282 |
| Johnson & Johnson | 8 | $230 |
| Mirum Pharmaceuticals, Inc. | 12 | $230 |
| AbbVie | 6 | $193 |
| Boston Scientific | 2 | $170 |
| Conmed Corporation | 1 | $165 |
| Sanofi | 4 | $138 |
| AstraZeneca | 3 | $69 |
| Alcresta Therapeutics, Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Pharming Healthcare, Inc. | 2 | $34 |
| Amgen | 1 | $25 |
| Mauna Kea Technologies, Inc. | 1 | $24 |
| Eton Pharmaceuticals, Inc. | 1 | $23 |
| Albireo Pharma, Inc. | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVIS EXERA III DUODENOVIDEOSCOPE$2,010
- CONMED HEMOSTASIS$165
- CONMED GENERATORS$165
- DUPIXENT$144
- Humira$125
- SPYGLASS$119
- Sucraid$112
How this compares
$6,272 in reported general payments places this provider in the 85th percentile of 159 pediatric gastroenterology providers in Texas.
Other pediatric gastroenterology in Dallas
- Naveen MittalDallas$182K
- Amal AqulDallas$99K
- Charina RamirezDallas$60K
- Meghana SatheDallas$30K
- David TroendleDallas$14K
- Nandini ChannabasappaDallas$12K
- Rinarani SanghaviDallas$6K
- Ricardo Medina-CentenoDallas$5K
- Megha MehtaDallas$4K
- Bhaskar GurramDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.